For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on October 17th, 2024 | 07:00 CEST
Big News for Nel, Evotec, and dynaCERT! Stock set for +100% or -20%?
Big news for Evotec. The analysts at Warburg see more than 100% upside potential. At the same time, however, they are warning of weak quarterly figures. Deutsche Bank even predicts a potential price drop. A long-awaited breakthrough came for dynaCERT. With VERRA's certification of HydraGEN products, trading in CO2 certificates is now possible, enabling new revenue opportunities for customers and dynaCERT. This could allow both dynaCERT and its stock to grow to a new level. At Nel, growth is slowing, and losses remain high. Is there any reason for hope?
Read
Commented by Fabian Lorenz on October 10th, 2024 | 07:00 CEST
50% profit margin? JinkoSolar, Nel ASA, and Desert Gold shares
A 50% profit margin? This is the prospect held out by the CEO of Desert Gold Ventures. The gold explorer aims to start production as early as next year. Even if the price of gold were to fall significantly, Desert would still be profitable. Or is a takeover perhaps on the cards? Unfortunately, Nel can only dream of such profit margins. The hydrogen specialist failed to establish a profitable business model during the boom phase. Now, orders are also drying up, and analysts are reducing the share price targets. And what is JinkoSolar doing? The Chinese company seems to be emerging as a winner from the solar crisis. However, even the market leader is feeling the effects of falling prices. Nevertheless, the share price has risen. Where is it worth entering?
Read
Commented by Fabian Lorenz on October 9th, 2024 | 07:15 CEST
Biotech comeback and takeover fantasy! BioNTech, Bayer, and Vidac Pharma
Money can be made in biotech shares again! However, investors need to look carefully. While Moderna is at a multi-year low, BioNTech and Vidac Pharma have gained over 50% in just a few months. Is there more to come? The chances are good, as both biotech companies have released promising news. Analysts see a tenfold increase in the case of Vidac Pharma, and the focus on the fight against cancer makes the Company a takeover candidate. The cancer specialist would also be a good fit for Bayer and BioNTech, and the share is still cheap. BioNTech is becoming an investment darling again and is focusing on AI. Bayer has yet to make the leap above EUR 30, and analysts are warning about the upcoming quarterly figures.
Read
Commented by Fabian Lorenz on October 3rd, 2024 | 14:05 CEST
100% with HelloFresh! Are Bayer and dynaCERT taking off next?
Since the low in June, the HelloFresh share has roughly doubled. Not bad for an MDAX-listed stock with a market capitalization of EUR 1.6 billion. Can it continue at this pace, or would it be better to take profits? Analysts weigh in with their assessment. dynaCERT shows great potential. With a new German CEO, the Canadian company aims to make diesel engines more efficient and low-emission in Europe. And what is Bayer doing? Will the positive news flow help it to break out of the consolidation?
Read
Commented by Fabian Lorenz on October 2nd, 2024 | 07:30 CEST
50% upside potential and more! TUI, BASF, Saturn Oil + Gas
Is BASF a buy after the strategy change? Yes, say the analysts at DZ Bank. The dividend cut is considered the right move, and the stock has around 20% upside potential. Analysts see more than 50% upside potential at Saturn Oil & Gas. The Company was recently named the fastest-growing oil company in Canada for the second time. It is rare to see such a growth champion also praised as a value play, making the stock worth a closer look. And what about TUI? The stock is struggling with the EUR 7 mark, but Deutsche Bank sees upside potential.
Read
Commented by Fabian Lorenz on September 27th, 2024 | 07:10 CEST
Better than Plug Power? Stocks of Siemens Energy and Altech Advanced Materials are taking off!
Are there new stars in the energy transition? Plug Power and Nel have likely squandered their status in recent years. Both companies are unable to get a grip on their losses, and growth is weakening. Now, Plug Power is trying a new approach. In contrast, Altech Advanced Materials is just getting started. The stock of the German battery hopeful gained 20% in the past week alone. The reason: the marketing of the revolutionary solid-state battery is picking up speed. The Altech battery is expected to solve a critical problem for renewable energy and holds billion-dollar potential. After the strong performance in the current year, does the Siemens Energy share still have potential? Will it reach a new annual high with its old CEO?
Read
Commented by Fabian Lorenz on September 24th, 2024 | 07:30 CEST
Boom in gold and travel: Barrick Gold CEO warns! TUI focuses on luxury! Globex Mining share with catch-up potential!
The gold price is receiving new momentum due to falling interest rates in the US. The takeover merry-go-round is also turning, but the Barrick Gold CEO is warning. Investors should keep an eye on developments in 2010. The Globex Mining share has a lot of catch-up potential. The business of the mining incubator is de-risked and around half of the projects are in the precious metals sector. Meanwhile, business is booming at TUI. Among other things, the Company plans to grow more strongly in the luxury segment. Nevertheless, investors and analysts do not seem convinced by the stock. Is this justified?
Read
Commented by Fabian Lorenz on September 19th, 2024 | 07:15 CEST
More than 100% with hydrogen stocks: Plug Power, thyssenkrupp nucera, First Hydrogen
Are hydrogen stocks making a comeback? In recent months, shareholders of Nel, Plug Power, and Co. have had little reason to celebrate. However, the bottom could have been reached for some stocks. Analysts see more than 100% upside potential for Thyssenkrupp Nucera, and the German company's hydrogen technology for heavy industry has won another award. First Hydrogen is among the innovators of hydrogen solutions for commercial vehicles. The Canadian company's fuel cell powertrain is to be installed in a proven light commercial vehicle of a major German vehicle manufacturer, and the next step in Germany is now following. And what is the problem child Plug Power doing? The hydrogen pioneer is back with a whole series of announcements. Is it worth getting in now?
Read
Commented by Fabian Lorenz on September 18th, 2024 | 07:15 CEST
Short squeeze, buy signal, and takeover speculation! Aixtron, HelloFresh, BlockchainK2!
Is there something brewing at HelloFresh? The stock has certainly surged, gaining more than 20% in value within a few days. There are insider purchases and a strong chart signal. Now, there is speculation of a short squeeze. Could the takeover rumors be coming back? BlockchainK2 could be a real bargain for a software company or a client from the financial industry. Thanks to blockchain and AI, the SaaS platform offers financial service providers cost and efficiency advantages. If interest rates fall, asset managers and the like will have to pay more attention to costs again. Accordingly, BlockchainK2 shares are attractive. Aixtron's share price is reacting positively to the news from the management board. Could this also lead to a short squeeze?
Read
Commented by Fabian Lorenz on September 16th, 2024 | 07:00 CEST
Big news at BioNTech! Soon also at Nyxoah? What about Sartorius?
The more than 10% jump in BioNTech's share price at the beginning of the week surprised many investors. Was this the starting signal for a sustained upward trend? The biotech company will publish important data in the coming days. Nyxoah is also getting ready for the big bang. The medical technology company is on the verge of entering the US market with its high-tech product. The Belgian company is fully financed to tap into the world's largest healthcare market. Are Nyxoah shares about to take off? The Sartorius share has started a countermovement in recent days. Is there more to come for the share price?
Read